Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
ABSTRACT Spironolactone (SPR) is a steroidal drug administered as a potassium-sparing diuretic for high blood pressure treatment. The drug shows incomplete gastrointestinal absorption due to its poor aqueous solubility. The physicochemical properties of SPR in crystal forms I and II suggest that dif...
Main Authors: | Renata Cunha de Resende, Olímpia Maria Martins Santos Viana, Jennifer Tavares Jacon Freitas, Rudy Bonfilio, André Luís Morais Ruela, Magali Benjamim de Araújo |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000400613&lng=en&tlng=en |
Similar Items
-
Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01) -
Improving the dissolution properties of spironolactone using liquisolid technique
by: Jafar Akbari, et al.
Published: (2015-09-01) -
Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01) -
Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01) -
Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014-12-01)